Guardian Pharmacy Services (GRDN) Stock Forecast: StockMap's 2-Week Call
GRDN stock forecast: StockMap's model makes no two-week call on Guardian Pharmacy Services after the Nov 19 close: its evidence is split, 3 reasons for and 12 against. Right in 2 of 5 two-week windows on GRDN since Aug 21; by chance, a call on the same dates was right 62% of the time.
Guardian Pharmacy Services last closed at $46.67, -4.44% on the session.
Against the IVW growth benchmark the position is -2.11% over the forecast window.
Guardian Pharmacy Services' market cap is $2.96B as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -13 (too close to call).
Where GRDN sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 3 bullish and 12 bearish.
Agreement across those insights is 80%.
25 daily calls for GRDN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Guardian Pharmacy Services in the 15th percentile on valuation and the 88th percentile on return on equity, where 100 is best.
Guardian Pharmacy Services is classified under Health Care / Health Care Providers & Services.
StockMap tracks Guardian Pharmacy Services as the 36th largest of the 87 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 52 Neutral, 18 Moderate Underperform, 12 Moderate Outperform and 5 Strong Underperform.
On that composite Guardian Pharmacy Services ranks 56th of 87 in the group, against a group median of -0.06.